Rare diseases
Investigational molecules
Locations
Back to Bulgaria168 clinical trials in Stara Zagora, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes
BulgariaComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
BulgariaA study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration
BulgariaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
BulgariaComparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery
BulgariaLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
BulgariaStudy on BJT-778 for Patients with Chronic Hepatitis Delta Infection
BulgariaStudy on the Effects of Tobevibart and Elebsiran Compared to Bulevirtide for Patients with Chronic Hepatitis D Virus Infection
BulgariaStudy on Maridebart Cafraglutide for Adults with Type 2 Diabetes and Obesity or Overweight
BulgariaStudy on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma
BulgariaStudy on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on inflammatory disorders are evaluating novel treatments for conditions including psoriatic arthritis and hidradenitis suppurativa. Researchers are testing innovative therapies targeting specific inflammatory pathways.
These studies aim to improve quality of life for patients with chronic inflammatory conditions.
Research in respiratory diseases includes multiple trials investigating new treatments for asthma. Studies are examining both established and experimental medications to enhance breathing function and disease control.
Emphasis is placed on developing treatments for moderate to severe cases.
Groundbreaking research in blood cancers and solid tumors includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, and prostate cancer. Novel therapeutic approaches are being evaluated.
These trials aim to improve survival rates and treatment outcomes.
Studies in neurological disorders are investigating treatments for epilepsy and examining extended-release formulations of existing medications to improve seizure control.
Focus is on developing more effective treatment options for patients with refractory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
